Entering text into the input field will update the search result below

Capricor announces new U.S. patent covering CAP-2003; shares ahead 28% premarket

Dec. 13, 2017 9:21 AM ETCapricor Therapeutics, Inc. (CAPR) StockBy: Douglas W. House, SA News Editor
  • Thinly traded nano cap Capricor Therapeutics (NASDAQ:CAPR) jumps 28% premarket on robust volume in response to its announcement that the USPTO has issued Patent No. 9,828,603, a composition of matter patent covering pipeline candidate CAP-2003, in development for the treatment of fibrotic diseases and inflammation.
  • CAP-2003 is a regenerative medicine therapy consisting of exosomes isolated from the company's cardiosphere-derived cells. Exosomes, nano-sized membrane-enclosed vesicles secreted by cells that contain proteins, RNAs and microDNAs, act as messengers to regulate cellular processes.
  • The patent was assigned to Cedars-Sinai Medical Center which granted Capricor exclusive global rights to the technology.

Recommended For You

More Trending News

About CAPR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CAPR--
Capricor Therapeutics, Inc.